0.87 USD
▲+0.01+0.59%
2026-08-03
市值
$38.55M
市盈率
0.96
EPS
0.91
股息率
—
52 周区间
0.50 – 2.50
成交量
28.06K
Beta
0.88
目标价
—
52W 低 0.5052W 高 2.50
价格走势
公司简介
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac pat...